News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PDI, Inc. (PDII) Reports 2012 Second Quarter Financial Results


8/14/2012 11:27:15 AM

PARSIPPANY, N.J., Aug. 13, 2012 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the second quarter ended June 30, 2012. Summary of second quarter and subsequent financial and operating highlights include:

  • Second quarter 2012 operating loss from continuing operations of $0.3 million improved 70% compared to a loss of $1.1 million during the second quarter of 2011.
  • Second quarter adjusted EBITDA was $0.8 million compared to $0.1 million in the same period of 2011.
  • Since the midpoint of the second quarter, announced new business wins, renewals and extensions expected to generate total combined revenues of approximately $102 million, with a projected $33 million to $35 million to be recorded in 2012, primarily in the second half. Wins included contracts with two, new top 10 global pharmaceutical companies and a number of new, mid-sized pharmaceutical companies.

Read at BioSpace.com

comments powered by Disqus
PDI, Inc.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES